VALONTAN * 10CPR RIV 100MG
Prevention and treatment of nausea, vomiting and vertigo, typical of naupathias (seasickness, car, train, plane sickness).
Dosage and method of use
VALONTAN Adult Coated tablets In naupathy, nausea and vomiting can be controlled with a single dose of ½ tablet of Valontan Adult (50 mg), the effect of which lasts for approximately 4 hours; this dose, if necessary, can be repeated, for preventive purposes, every 4 hours (3 tablets in 24 hours). VALONTAN Adult Suppositories To be used 1 - 3 times a day in adults when the oral route is not practicable. Do not exceed the recommended dose. Do not use for prolonged treatments.
Hypersensitivity to the active substance, to other antihistamines, or to any of the excipients. Contraindicated in children under 2 years of age. Generally contraindicated during pregnancy and lactation.
The most frequent side effect of antihistamines is sedation which can manifest as drowsiness. With the use of antihistamines, dry mouth, photosensitivity, accommodation disorders, urination disorders, headache, anorexia, nausea, allergic skin reactions may also occur. Less frequently dizziness, asthenia, insomnia (especially in children), euphoria, tremors, hypotension, tachycardia and, at high doses, especially in children, convulsions.
The use of antihistamines at the same time as certain antibiotics or other ototoxic drugs can mask the first signs of ototoxicity, which can only reveal itself when the damage is irreversible. Use with caution in subjects suffering from glaucoma, prostatic hypertrophy, other syndromes of urinary retention, intestinal obstruction, arterial hypertension, cardiovascular disease, bronchial asthma, chronic bronchitis or emphysema, hyperthyroidism. The medicine can exacerbate seizure disorders. It should therefore be used with great caution in subjects suffering from epilepsy. The tablets contain sucrose , are therefore not suitable for subjects with hereditary fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase deficiency.
Pregnancy and breastfeeding
Not recommended for use during pregnancy. In breastfeeding patients it is necessary to decide whether to give up breastfeeding the baby and start treatment or, vice versa, continue breastfeeding avoiding the administration of the product.
Expiration and retention
Interactions with other drugs
During treatment, avoid the simultaneous use of alcoholic beverages and antidepressant, hypnotic, sedative or tranquilizing drugs, in order to prevent any additive phenomena of sedation (see also section 4.7).
Sleepiness is the most usual symptom of overdosing. Toxic doses can produce: convulsion, coma and respiratory depression. If necessary, implement symptomatic therapy. When needed, respiratory assistance.
Tablets Each coated tablet contains: Active principle Dimenhydrinate 100 mg Suppositories Each suppository contains: Active principle Dimenhydrinate 100 mg For excipients: see 6.1
Coated tablets Each coated tablet contains: Excipients sucrose 16.0 mg precipitated silica 5.0 mg magnesium stearate 7.0 mg maize starch 97.0 mg Coating components acrylic resin (Eudragit) 2.8 mg talc 0.2 mg Suppositories Each suppository contains: Excipients colloidal silica 25 mg semisynthetic glycerides 1.675 g